BlackRock’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$854M Buy
10,806,724
+309,310
+3% +$26.3M 0.01% 858
2026
Q1
$904M Buy
10,497,414
+213,321
+2% +$19.1M 0.02% 746
2025
Q4
$898M Sell
10,284,093
-249,226
-2% -$18.9M 0.02% 740
2025
Q3
$603M Sell
10,533,319
-230,169
-2% -$13.3M 0.01% 965
2025
Q2
$635M Buy
10,763,488
+39,577
+0.4% +$2.56M 0.01% 892
2025
Q1
$785M Buy
10,723,911
+87,068
+0.8% +$7.19M 0.02% 741
2024
Q4
$880M Buy
10,636,843
+363,165
+4% +$28.6M 0.02% 722
2024
Q3
$735M Sell
10,273,678
-66,166
-0.6% -$4.67M 0.02% 813
2024
Q2
$708M Sell
10,339,844
-543,514
-5% -$32.5M 0.02% 782
2024
Q1
$584M Buy
10,883,358
+41,301
+0.4% +$2.22M 0.01% 923
2023
Q4
$578M Sell
10,842,057
-196,362
-2% -$9.57M 0.01% 897
2023
Q3
$548M Buy
11,038,419
+3,682,601
+50% +$206M 0.02% 834
2023
Q2
$438M Sell
7,355,818
-152,702
-2% -$8.7M 0.01% 1021
2023
Q1
$425M Buy
7,508,520
+33,806
+0.5% +$2.17M 0.01% 1023
2022
Q4
$555M Buy
7,474,714
+218,709
+3% +$14.9M 0.02% 810
2022
Q3
$432M Sell
7,256,005
-199,412
-3% -$12M 0.01% 905
2022
Q2
$419M Buy
7,455,417
+107,559
+1% +$7.07M 0.01% 974
2022
Q1
$542M Buy
7,347,858
+48,913
+0.7% +$3.4M 0.01% 914
2021
Q4
$527M Sell
7,298,945
-1,521
-0% -$110K 0.01% 985
2021
Q3
$559M Sell
7,300,466
-45,033
-0.6% -$3.62M 0.02% 897
2021
Q2
$569M Sell
7,345,499
-216,384
-3% -$15.4M 0.02% 924
2021
Q1
$466M Buy
7,561,883
+155,981
+2% +$9.88M 0.01% 1068
2020
Q4
$483M Buy
7,405,902
+204,321
+3% +$11.7M 0.02% 921
2020
Q3
$357M Sell
7,201,581
-370,916
-5% -$19.1M 0.01% 954
2020
Q2
$361M Sell
7,572,497
-1,871,333
-20% -$90.3M 0.01% 921
2020
Q1
$402M Sell
9,443,830
-173,303
-2% -$8.56M 0.02% 727
2019
Q4
$566M Buy
9,617,133
+215,438
+2% +$11.7M 0.02% 720
2019
Q3
$481M Sell
9,401,695
-228,100
-2% -$10.9M 0.02% 779
2019
Q2
$407M Buy
9,629,795
+89,022
+0.9% +$3.87M 0.02% 878
2019
Q1
$471M Buy
9,540,773
+26,994
+0.3% +$1.22M 0.02% 767
2018
Q4
$412M Buy
9,513,779
+57,503
+0.6% +$2.87M 0.02% 757
2018
Q3
$537M Buy
9,456,276
+254,550
+3% +$13.4M 0.02% 712
2018
Q2
$464M Buy
9,201,726
+1,190,681
+15% +$62.1M 0.02% 782
2018
Q1
$399M Buy
8,011,045
+211,428
+3% +$9.94M 0.02% 849
2017
Q4
$321M Buy
7,799,617
+159,963
+2% +$5.6M 0.02% 1022
2017
Q3
$227M Buy
7,639,654
+191,234
+3% +$5.84M 0.01% 1244
2017
Q2
$247M Buy
7,448,420
+61,138
+0.8% +$1.92M 0.01% 1124
2017
Q1
$219M Buy
7,387,282
+7,355,279
+22,983% +$201M 0.01% 1205
2016
Q4
$795K Buy
32,003
+25,129
+366% +$571K ﹤0.01% 1572
2016
Q3
$155K Buy
6,874
+747
+12% +$17.6K ﹤0.01% 2329
2016
Q2
$146K Buy
6,127
+1,129
+23% +$27.1K ﹤0.01% 2285
2016
Q1
$119K Buy
4,998
+2,970
+146% +$72.6K ﹤0.01% 1922
2015
Q4
$56K Buy
2,028
+327
+19% +$8.21K ﹤0.01% 1987
2015
Q3
$35K Hold
1,701
﹤0.01% 2074
2015
Q2
$44K Sell
1,701
-85
-5% -$2.15K ﹤0.01% 2026
2015
Q1
$45K Hold
1,786
﹤0.01% 1994
2014
Q4
$42K Hold
1,786
﹤0.01% 2016
2014
Q3
$35K Hold
1,786
﹤0.01% 2078
2014
Q2
$42K Buy
1,786
+409
+30% +$9.87K ﹤0.01% 2016
2014
Q1
$37K Hold
1,377
﹤0.01% 2056
2013
Q4
$28K Sell
1,377
-83
-6% -$1.54K ﹤0.01% 2188
2013
Q3
$25K Buy
1,460
+111
+8% +$1.92K ﹤0.01% 2154
2013
Q2
$23K Buy
+1,349
New +$20.8K ﹤0.01% 2229

Other funds holding GMED

BlackRock's GMED Position: Q2 2026 in Review

BlackRock increased its Globus Medical (GMED) stake by 2.9% in Q2 2026, buying an estimated $26.3M and bringing the position to 10,806,724 shares worth $854M. The position accounts for 0.01% of the portfolio, ranked #858.

BlackRock first reported a position in GMED in Q2 2013 and has held it in 53 quarters since. The position peaked at $904M in Q1 2026. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • BlackRock held 10,806,724 shares of Globus Medical worth $854M as of Q2 2026.
  • BlackRock bought 309,310 Globus Medical shares in Q2 2026, an estimated $26.3M.
  • Globus Medical made up 0.01% of BlackRock's portfolio in Q2 2026, its #858 holding.
  • BlackRock first reported a position in Globus Medical in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Globus Medical position peaked at $904M in Q1 2026.
  • 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.